Massive hemoptysis due to mycobacterium fortuitum infection controlled with bronchial artery embolization - A case report

被引:4
作者
Abe, Y
Nakamura, M
Suzuki, K
Hashizume, T
Tanigaki, T
Saito, T
Fujino, T
Kikuchi, K
机构
[1] Natl Sanatorium Kanagawa Hosp, Dept Resp Dis, Kanagawa 2578585, Japan
[2] Dept Resp Med, Kanagawa 2591193, Japan
[3] Dept Radiol, Kanagawa 2591193, Japan
关键词
hemoptysis; mycobacterium fortuitum; bronchial artery embolization;
D O I
10.1016/S0899-7071(00)00163-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We reported a case of first reported pulmonary infection due to Mycobacterium fortuitum (M. fortuitum) with massive hemoptysis, successfully treated by bronchial artery embolization (BAE). A 78-year-old male was admitted to our hospital complaining of massive hemoptysis. A biochemical examination and DNA/DNA hybridization revealed M. fortuitum in the culture of his sputum. He was treated by BAE, and antituberculous agents and levofloxacin. The patient remains well without recurrence more than one and a half years after the admission. (C) Elsevier Science Inc., 2000.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 10 条
[1]   OTHER MYCOBACTERIA [J].
DAVIDSON, PT .
CHEST, 1979, 75 (02) :110-111
[2]   CLINICAL-FEATURES OF PULMONARY-DISEASE CAUSED BY RAPIDLY GROWING MYCOBACTERIA - AN ANALYSIS OF 154 PATIENTS [J].
GRIFFITH, DE ;
GIRARD, WM ;
WALLACE, RJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (05) :1271-1278
[3]   MYCOBACTERIUM-FORTUITUM - HUMAN PATHOGEN [J].
HAND, WL ;
SANFORD, JP .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) :971-+
[4]  
HAYAKAWA K, 1992, CARDIOVASC INTER RAD, V15, P154, DOI 10.1007/BF02735578
[5]  
KNOTTCRAIG CJ, 1993, J THORAC CARDIOV SUR, V105, P394
[6]   Massive hemoptysis due to pulmonary tuberculosis: Control with bronchial artery embolization [J].
Ramakantan, R ;
Bandekar, VG ;
Gandhi, MS ;
Aulakh, BG ;
Deshmukh, HL .
RADIOLOGY, 1996, 200 (03) :691-694
[7]  
SWENSON JM, 1985, ANTIMICROB AGENTS CH, V28, P807, DOI 10.1128/AAC.28.6.807
[8]   Treatment of nontuberculous mycobacterial infections: Role of clarithromycin and azithromycin [J].
Tartaglione, T .
CLINICAL THERAPEUTICS, 1997, 19 (04) :626-638
[9]  
Tsumatori G, 1990, Kekkaku, V65, P483
[10]  
WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107